These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14574238)

  • 61. Can reduced drinking be a viable goal for alcohol dependent patients?
    Mann K; Aubin HJ; Charlet K; Witkiewitz K
    World Psychiatry; 2017 Oct; 16(3):325-326. PubMed ID: 28941117
    [No Abstract]   [Full Text] [Related]  

  • 62. Patient-Treatment Matching: Rationale and Results.
    Mattson ME
    Alcohol Health Res World; 1994; 18(4):287-295. PubMed ID: 31798094
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Selecting efficacious Bcl-2 family inhibitors for optimal clinical outcome.
    Muqbil I; Mohammad RM
    Ann Transl Med; 2015 Nov; 3(20):312. PubMed ID: 26697472
    [No Abstract]   [Full Text] [Related]  

  • 64. Re: Selecting Optimal Subgroups for Treatment Using Many Covariates.
    Kent DM; van Klaveren D
    Epidemiology; 2020 May; 31(3):e30-e31. PubMed ID: 31880640
    [No Abstract]   [Full Text] [Related]  

  • 65. Re. Selecting Optimal Subgroups for Treatment Using Many Covariates.
    Penning de Vries BBL; Groenwold RHH; Luedtke A
    Epidemiology; 2020 Jul; 31(4):e33-e34. PubMed ID: 32282408
    [No Abstract]   [Full Text] [Related]  

  • 66. Using ecological momentary assessments of negative affect and craving during residential opioid use disorder treatment to predict patients' relapse to substance use.
    Cleveland HH; Knapp KS; Cleveland MJ; Deneke E; Bunce SC
    J Subst Use Addict Treat; 2023 Mar; 146():208931. PubMed ID: 36880896
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association of Hypomagnesemia and Liver Injury, Role of Gut-Barrier Dysfunction and Inflammation: Efficacy of Abstinence, and 2-Week Medical Management in Alcohol Use Disorder Patients.
    Winrich EJ; Gala KS; Rajhans A; Rios-Perez CD; Royer AJ; Zamani Z; Parthasarathy R; Marsano-Obando LS; Barve AJ; Schwandt ML; Vatsalya V
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232646
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and comparative effectiveness of telephone and smartphone remote continuing care interventions for alcohol use disorder: a randomized controlled trial.
    McKay JR; Gustafson DH; Ivey M; Pe-Romashko K; Curtis B; Thomas T; Oslin DW; Polsky D; Quanbeck A; Lynch KG
    Addiction; 2022 May; 117(5):1326-1337. PubMed ID: 34859519
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Belief in the myth of an American Indian/Alaska Native biological vulnerability to alcohol problems among reservation-dwelling participants with a substance use problem.
    Gonzalez VM; Skewes MC
    Alcohol Clin Exp Res; 2021 Nov; 45(11):2309-2321. PubMed ID: 34837658
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy of Thiamine and Medical Management in Treating Hyperuricemia in AUD Patients with ALD: Role of Hyperuricemia in Liver Injury, Gut-Barrier Dysfunction, and Inflammation.
    Vatsalya V; Li F; Frimodig J; Shah N; Sutrawe A; Feng W
    Clin Exp Pharmacol; 2021; 11(Suppl 7):. PubMed ID: 34522469
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effectiveness and Utility of Mobile Device Assessment of Subjective Craving during Residential Opioid Dependence Treatment.
    Cleveland HH; Knapp KS; Brick TR; Russell MA; Gajos JM; Bunce SC
    Subst Use Misuse; 2021; 56(9):1284-1294. PubMed ID: 34057031
    [No Abstract]   [Full Text] [Related]  

  • 72. Daily meaningfulness among patients with opioid use disorder: Examining the role of social experiences during residential treatment and links with post-treatment relapse.
    Knapp KS; Brick TR; Bunce SC; Deneke E; Cleveland HH
    Addict Behav; 2021 Aug; 119():106914. PubMed ID: 33857730
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Recovery from Alcohol Consumption: Analysis of the Construct of Relapse.
    Reyes-Huerta HE; Vacio Á; Pedroza F; Salazar M; Martínez K
    Int J Psychol Res (Medellin); 2018; 11(1):70-82. PubMed ID: 32612772
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dysregulation in Plasma
    Vatsalya V; Agrawal R; Frimodig J; Srivastava S; Schwandt ML
    Adv Virol; 2020; 2020():7835875. PubMed ID: 32565809
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characteristics of Ongoing Clinical Trials for Alcohol Use Disorder Registered on ClinicalTrials.gov.
    Wallach JD; Krystal JH; Ross JS; O'Malley SS
    JAMA Psychiatry; 2020 Oct; 77(10):1081-1084. PubMed ID: 32459295
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lower Serum Magnesium Concentrations are associated With Specific Heavy Drinking Markers, Pro-Inflammatory Response and Early-Stage Alcohol-associated Liver Injury§.
    Vatsalya V; Gala KS; Mishra M; Schwandt ML; Umhau J; Cave MC; Parajuli D; Ramchandani VA; McClain CJ
    Alcohol Alcohol; 2020 Mar; 55(2):164-170. PubMed ID: 32047901
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Consumption outcomes in clinical trials of alcohol use disorder treatment: Consideration of standard drink misestimation.
    Kirouac M; Kruger E; Wilson AD; Hallgren KA; Witkiewitz K
    Am J Drug Alcohol Abuse; 2019; 45(5):451-459. PubMed ID: 30870054
    [No Abstract]   [Full Text] [Related]  

  • 78. Assessment of Skin Blood Flow Following Acute Intravenous Alcohol, and Association with Subjective Perceptions, in Social Drinkers.
    Vatsalya V; Stangl BL; Ramchandani VA
    Alcohol Clin Exp Res; 2019 Mar; 43(3):405-410. PubMed ID: 30735255
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder.
    Lee DC; Schlienz NJ; Peters EN; Dworkin RH; Turk DC; Strain EC; Vandrey R
    Drug Alcohol Depend; 2019 Jan; 194():500-517. PubMed ID: 30530238
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association of serum zinc with markers of liver injury in very heavy drinking alcohol-dependent patients.
    Vatsalya V; Kong M; Cave MC; Liu N; Schwandt ML; George DT; Ramchandani VA; McClain CJ
    J Nutr Biochem; 2018 Sep; 59():49-55. PubMed ID: 29960116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.